Advertisement
Canada markets close in 4 hours 5 minutes
  • S&P/TSX

    21,851.01
    -160.71 (-0.73%)
     
  • S&P 500

    5,054.92
    -15.63 (-0.31%)
     
  • DOW

    38,342.11
    -161.58 (-0.42%)
     
  • CAD/USD

    0.7288
    -0.0032 (-0.44%)
     
  • CRUDE OIL

    82.67
    -0.69 (-0.83%)
     
  • Bitcoin CAD

    88,766.08
    -2,526.05 (-2.77%)
     
  • CMC Crypto 200

    1,402.21
    -21.89 (-1.54%)
     
  • GOLD FUTURES

    2,338.80
    -3.30 (-0.14%)
     
  • RUSSELL 2000

    1,990.76
    -11.88 (-0.59%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ

    15,677.86
    -18.78 (-0.12%)
     
  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6817
    -0.0019 (-0.28%)
     

Will Amgen's Rivals Pop On Its Cholesterol-Busting Drug?

Will Amgen's Rivals Pop On Its Cholesterol-Busting Drug?

Amgen will likely have Wall Street tuned in during Wednesday's first-quarter earnings call to see whether a 2.2-year cholesterol study could prompt stronger reimbursement trends.